click below
click below
Normal Size Small Size show me how
Mod 4 PT Final
Question | Answer |
---|---|
A tablet that releases one dose immediately and then releases a second dose sometime later is a ---- tablet. | modified release |
Drugs can pass through biological membranes | Through aqueous pores, by active transport, and by passive diffusion (all of the above) |
Extended agonist stimulation leads to a | Decrease number of receptors |
Bioequivalency is determined by comparing the ---- two products | bioavailabilities |
In the blood concentration-time profile, the duration of action can be measured as the | time from when blood concentrations first reaches the MEC to when the declining blood concentrations reaches then falls below the MEC |
Levofloxacin has been shown to bind to calcium, magnesium, and aluminum ions and decrease the bioavailability of levofloxacin. What type of drug-drug interaction is this? | complex formation |
What criteria should not be used to determine drug dosages for infants? | age alone |
Which is not a mechanism of drug action? | changes in metabolism, chemical reaction, and protective/physical. (all of the above) |
Interactions that alter drug absorption can be minimized by separating the administration of the drug and food intake by: | 2 hours |
Which route of administration does not have an absorption step? | intravenous |
When a drug is displaced from serum protein by a stronger binding drug the amount of drug A will | increase the amount of free drug A |
The ---- is the blood concentration needed to produce a response. | Minimum effective concentration (MEC) |
As blood concentrations fall in a blood concentration-time profile ---- is the predominant process | distribution and metabolism |
Extended antagonist stimulation leads to a | increased number of receptors |
When drug molecules are bound to plasma or tissue proteins they are | inactive |
Pharmaceutical alternatives have the | same active ingredient, different salt form of the active ingredient and different dosage forms. (all of the above) |
Drugs bind to many proteins, plasma proteins | drug remains biologically inactive |
Elderly patients may experience more drug interactions than other populations because | all of the above |
Which is not a means of losing orally administered drug? | administer a solution |
most drugs given orally are absorbed into the blood from the | small intestine |
The percentage or fraction of an administered dose of a drug that actually reaches the systemic circulation and the rate at which this occurs is the drug's | bioavailability |
To avoid first-pass metabolism, administer the drug | by a parenteral route |
---- occurs when two drugs with similar pharmacological actions result in effect equal to the sum of their individual affects. | additive effect |
most drugs given orally are absorbed into the blood from the | small intestine |
Glomerular filtration is the blood filter process of the | kidney |
What would not be responsible for increased drug bioavailibility in hepatic disease? | increased first pass effect |
in metabolism, the breakdown of drugs into metabolites is caused by | enzymes |
When a drug binds to a receptor and affects the normal cellular process, it is an | agonist |
the place where a drug causes an effect to occur is | site of action |
which set of circumstances will result in a drug undergoing urinary excretion but not urinary re-absorption? | basic drug in low pH urine |
which physiological change occurs during pregnancy? | decreased gastric emptying |
First-pass metabolism refers to the substantial degradation of the drug caused by enzyme metabolism in the | liver |
Bioavailability measures | rate and extent the drug is available to the site of action |
most drugs and their metabolites are excreted by the | kidneys |
what does first pass metabolism have on drug absorption? | decrease absorption |
Which is generally a characteristic of a Type A ADR | dose-dependent |
Spinach and other green vegetables contain vitamin ---- that inhibits the action of oral anticoagulants | K |
Tissue protein | acts as a depot for the drug |